Clinical Trial Protocol for ProBio-mHSPC: A ctDNA-driven De-escalation and Intensification Platform Trial for Metastatic Hormone-sensitive Prostate Cancer

Bram De Laere, Alessio Crippa, Andrea Discacciati, Ashkan Mortezavi, Christoph Müller, Andreas Røder, Antti Rannikko, Piet Ost, Martin Eklund, Johan Lindberg, Henrik Grönberg, Marie Hjälm-Eriksson, Anders Ullén, Gunilla Enblad, Camilla Thellenberg Karlsson, Elin Jänes, Martha Olsson, Mats Andén, Linn Pettersson, Johan Staby Olsén, Ingrida Verbiene, Christine Jaredsson, Jenny Kahlmeter Brandell, Nicolaas Lumen, Christophe Ghysel, Els Everaert, Wendy De Roock, Siska Van Bruwaene, Brieuc Sautois, Peter Schatteman, Simon Van Wambeke, Guillaume Grisay, Christof Vulsteke, Jan Oldenburg, Maria Nyre Vigmostad, Hege Sagstuen Haugnes, Christoph Müller, Corina Emilia Idu, Bjørg Yksnøy Aksnessæther, Frank Stenner, Christoph Mamot, Lukas Prause, Arnoud Templeton

Open source

DOI: 10.1016/j.euf.2026.04.018
Published: 2026-05
Container: European Urology Focus
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.euf.2026.04.018,
  title = {Clinical Trial Protocol for ProBio-mHSPC: A ctDNA-driven De-escalation and Intensification Platform Trial for Metastatic Hormone-sensitive Prostate Cancer},
  author = {Bram De Laere and Alessio Crippa and Andrea Discacciati and Ashkan Mortezavi and Christoph Müller and Andreas Røder and Antti Rannikko and Piet Ost and Martin Eklund and Johan Lindberg and Henrik Grönberg and Marie Hjälm-Eriksson and Anders Ullén and Gunilla Enblad and Camilla Thellenberg Karlsson and Elin Jänes and Martha Olsson and Mats Andén and Linn Pettersson and Johan Staby Olsén and Ingrida Verbiene and Christine Jaredsson and Jenny Kahlmeter Brandell and Nicolaas Lumen and Christophe Ghysel and Els Everaert and Wendy De Roock and Siska Van Bruwaene and Brieuc Sautois and Peter Schatteman and Simon Van Wambeke and Guillaume Grisay and Christof Vulsteke and Jan Oldenburg and Maria Nyre Vigmostad and Hege Sagstuen Haugnes and Christoph Müller and Corina Emilia Idu and Bjørg Yksnøy Aksnessæther and Frank Stenner and Christoph Mamot and Lukas Prause and Arnoud Templeton},
  year = {2026},
  journal = {European Urology Focus},
  doi = {10.1016/j.euf.2026.04.018},
  url = {https://doi.org/10.1016/j.euf.2026.04.018}
}

RIS

TY  - JOUR
TI  - Clinical Trial Protocol for ProBio-mHSPC: A ctDNA-driven De-escalation and Intensification Platform Trial for Metastatic Hormone-sensitive Prostate Cancer
AU  - Bram De Laere
AU  - Alessio Crippa
AU  - Andrea Discacciati
AU  - Ashkan Mortezavi
AU  - Christoph Müller
AU  - Andreas Røder
AU  - Antti Rannikko
AU  - Piet Ost
AU  - Martin Eklund
AU  - Johan Lindberg
AU  - Henrik Grönberg
AU  - Marie Hjälm-Eriksson
AU  - Anders Ullén
AU  - Gunilla Enblad
AU  - Camilla Thellenberg Karlsson
AU  - Elin Jänes
AU  - Martha Olsson
AU  - Mats Andén
AU  - Linn Pettersson
AU  - Johan Staby Olsén
AU  - Ingrida Verbiene
AU  - Christine Jaredsson
AU  - Jenny Kahlmeter Brandell
AU  - Nicolaas Lumen
AU  - Christophe Ghysel
AU  - Els Everaert
AU  - Wendy De Roock
AU  - Siska Van Bruwaene
AU  - Brieuc Sautois
AU  - Peter Schatteman
AU  - Simon Van Wambeke
AU  - Guillaume Grisay
AU  - Christof Vulsteke
AU  - Jan Oldenburg
AU  - Maria Nyre Vigmostad
AU  - Hege Sagstuen Haugnes
AU  - Christoph Müller
AU  - Corina Emilia Idu
AU  - Bjørg Yksnøy Aksnessæther
AU  - Frank Stenner
AU  - Christoph Mamot
AU  - Lukas Prause
AU  - Arnoud Templeton
PY  - 2026
JO  - European Urology Focus
DO  - 10.1016/j.euf.2026.04.018
UR  - https://doi.org/10.1016/j.euf.2026.04.018
ER  -

APA

Laere, B. D., Crippa, A., Discacciati, A., Mortezavi, A., Müller, C., Røder, A., Rannikko, A., Ost, P., Eklund, M., Lindberg, J., Grönberg, H., Hjälm-Eriksson, M., Ullén, A., Enblad, G., Karlsson, C. T., Jänes, E., Olsson, M., Andén, M., Pettersson, L., Olsén, J. S., Verbiene, I., Jaredsson, C., Brandell, J. K., Lumen, N., Ghysel, C., Everaert, E., Roock, W. D., Bruwaene, S. V., Sautois, B., Schatteman, P., Wambeke, S. V., Grisay, G., Vulsteke, C., Oldenburg, J., Vigmostad, M. N., Haugnes, H. S., Müller, C., Idu, C. E., Aksnessæther, B. Y., Stenner, F., Mamot, C., Prause, L., & Templeton, A. (2026). Clinical Trial Protocol for ProBio-mHSPC: A ctDNA-driven De-escalation and Intensification Platform Trial for Metastatic Hormone-sensitive Prostate Cancer. European Urology Focus. https://doi.org/10.1016/j.euf.2026.04.018

Source records

crossref · retrieved 2026-09-27T05:52:13.546Z